Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm: Peripheral vs Central Administration

Neuropsychopharmacology

Volumn 36, Issue 12, 2011, Pages 2488-2497

  Ayers, Luke W ^a   Missig, Galen ^b   Schulkin, Jay ^c,d,e   Rosen, Jeffrey B ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

Author keywords

anxiety; fear; oxytocin; PTSD; startle

Indexed keywords

OXYTOCIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN VENTRICLE; CANNULATION; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL STUDY; FEAR; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SCORING SYSTEM; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; ANXIETY; FEAR; INFUSIONS, INTRAVENTRICULAR; INFUSIONS, SUBCUTANEOUS; MALE; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION;

EID: 80054751601     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.138     Document Type: Article

References (77)

1. Amico JA, Vollmer RR, Karam JR, Lee PR, Li X, Koenig JI et al (2004). Centrally administered oxytocin elicits exaggerated grooming in oxytocin null mice. Pharmacol, Biochem, Behav 78: 333-339. (Pubitemid 38829370)
2. Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM (2001). CNS region-specific oxytocin receptor expression: Importance in regulation of anxiety and sex behavior. J Neurosci 21: 2546-2552. (Pubitemid 32240551)
3. Bartz J, Hollander E (2008). Oxytocin and experimental therapeutics in autism spectrum disorders. Prog Brain Res 170: 451-462. (Pubitemid 352010247)
4. Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A et al (2010). Oxytocin selectively improves empathic accuracy. Psychol Sci 21: 1426-1428.
5. Bernier R, Dawson G, Panagiotides H, Webb S (2005). Individuals with autism spectrum disorder show normal responses to a fear potential startle paradigm. J Autism Dev Disord 35: 575-583.
6. Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M et al (2008). Oxytocin reduces anxiety via ERK1/2 activation: Local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 27: 1947-1956. (Pubitemid 351521499)
7. Boccia MM, Kopf SR, Baratti CM (1998). Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice. Neurobiol Learn Mem 69: 136-146. (Pubitemid 28364513)
8. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002). Sniffing neuropeptides: A transnasal approach to the human brain. Nat Neurosci 5: 514-516. (Pubitemid 34568991)
9. Brasnjevic I, Steinbusch HWM, Schmitz C, Martinez-Martinez P (2009). Delivery of peptide and protein drugs over the bloodbrain barrier. Prog Neurobiol 87: 212-251.
10. Brunetti M, Sepede G, Mingoia G, Catani C, Ferretti A, Merla A et al (2010). Elevated response of human amygdala to neutral stimuli in mild post traumatic stress disorder: Neural correlates of generalized emotional response. Neuroscience 168: 670-679.
11. Buijs R, de Vries G, van Leeuwen FW (1985). The distribution and synaptic release of oxytocin in the central nervous system, In: Amico J, Robinson A (eds). Oxytocin: Clincial and Laboratory Studies. Elsevier: Amsterdam. pp 77-86.
12. Buijs RM (1980). Immunocytochemical demonstration of vasopressin and oxytocin in the rat brain by light and electron microscopy. J Histochem Cytochem 28: 357-360. (Pubitemid 10134666)
13. Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC et al (2010). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict Biol 15: 448-463.
14. Carter C, Grippo A, Pournajafi-Nazarloo H, Ruscio M, Porges S (2008). Oxytocin, vasopressin and sociality. Prog Brain Res 170: 331-336. (Pubitemid 352010239)
15. Colbern DL, Gispen WH (1988). Neural mechanisms and biological significance of grooming behavior. Ann N Y Acad Sci 525: Ix-x.
16. Davis M, Falls WA, Campeau S, Kim M (1993). Fear-potentiated startle: A neural and pharmacological analysis. Behav Brain Res 58: 175-198. (Pubitemid 24024057)
17. Davis M, Walker DL, Miles L, Grillon C (2010). Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35: 105-135.
18. Davis M, Whalen PJ (2001). The amygdala: Vigilance and emotion. Mol Psychiatry 6: 13-34. (Pubitemid 32096061)
19. de Oliveira LF, Camboim C, Diehl F, Consiglio AR, Quillfeldt JA (2007). Glucocorticoid-mediated effects of systemic oxytocin upon memory retrieval. Neurobiol Learn Mem 87: 67-71. (Pubitemid 44755269)
20. de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM (1987). Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J Pharmacol Exp Ther 241: 268-274. (Pubitemid 17119370)
21. Dichter GS, Benning SD, Holtzclaw TN, Bodfish JW (2010). Affective modulation of the startle eyeblink and postauricular reflexes in autism spectrum disorder. J Autism Dev Disord 40: 858-869.
22. Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC (2007). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187-1190. (Pubitemid 350029722)
23. Drago F, Pedersen CA, Caldwell JD, Prange AJ (1986). Oxytocin potently enhances novelty-induced grooming behavior in the rat. Brain Res 368: 287-295. (Pubitemid 16046180)
24. Durham DA, Banks WA, Kastin AJ (1991). Carrier-mediated transport of labeled oxytocin from brain to blood. Neuroendocrinology 53: 447-452.
25. Ermisch A, Barth T, Ruhle HJ, Skopkova J, Hrbas P, Landgraf R (1985). On the blood-brain barrier to peptides: Accumulation of labeled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Endocrinol Exp 19: 29-37. (Pubitemid 15062320)
26. Ermisch A, Brust P, Kretzschmar R, Rühle HJ (1993). Peptides and blood-brain barrier transport. Physiol Rev 73: 489-527. (Pubitemid 23204850)
27. Francis AB, Pace TW, Ginsberg AB, Rubin BA, Spencer RL (2006). Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: Implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis. Neuroscience 141: 1503-1515. (Pubitemid 44144512)
28. Gibbs J, Kulkosky PJ, Smith GP (1981). Effects of peripheral and central bombesin on feeding behavior of rats. Peptides 2(Suppl 2): 179-183. (Pubitemid 12118300)
29. Gimpl G, Fahrenholz F (2001). The oxytocin receptor system: Structure, function, and regulation. Physiol Rev 81: 629-683. (Pubitemid 32267075)
30. Grillon C (2002). Startle reactivity and anxiety disorders: Aversive conditioning, context, and neurobiology. Biol Psychiatry 52: 958-975. (Pubitemid 35356354)
31. Grillon C (2009). D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry 66: 636-641.
32. Grillon C, Baas J (2003). A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114: 1557-1579. (Pubitemid 37025791)
33. Grillon C, Lissek S, Rabin S, Mcdowell D, Dvir S, Pine DS (2008). Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry 165: 898-904. (Pubitemid 351948722)
34. Grillon C, Morgan CA (1999). Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol 108: 134-142. (Pubitemid 29108316)
35. Grillon C, Morgan III CA, Davis M, Southwick SM (1998). Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44: 1027-1036. (Pubitemid 28545231)
36. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS (1996). Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res 64: 169-178. (Pubitemid 26380236)
37. Grillon C, Pine DS, Lissek S, Rabin S, Bonne O, Vythilingam M (2009). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol Psychiatry 66: 47-53.
38. Grippo AJ, Trahanas DM, Zimmerman II RR, Porges SW, Carter CS (2009). Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 34: 1542-1553.
39. Hogle JM, Kaye JT, Curtin JJ (2010). Nicotine withdrawal increases threat-induced anxiety but not fear: Neuroadaptation in human addiction. Biol Psychiatry 68: 719-725.
40. Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L et al (2007). Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61: 498-503. (Pubitemid 46185336)
41. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR et al (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28: 193-198.
42. Johnson AK, Epstein AN (1975). The cerebral ventricles as the avenue for the dipsogenic action of intracranial angiotensin. Brain Res 86: 399-418.
43. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S et al (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25: 11489-11493. (Pubitemid 43083720)
44. Kiss A, Mikkelsen JD (2005). OxytocinFanatomy and functional assignments: A minireview. Endocr Regul 39: 97-105.
45. Klenerova V, Krejci I, Sida P, Hlinak Z, Hynie S (2009). Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field. J Physiol Pharmacol 60: 57-62.
46. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005). Oxytocin increases trust in humans. Nature 435: 673-676. (Pubitemid 40825511)
47. Liberzon I, Sripada CS (2008). The functional neuroanatomy of PTSD: A critical review. Prog Brain Res 167: 151-169.
48. Mens WB, Witter A, van Wimersma Greidanus TB (1983). Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF. Brain Res 262: 143-149. (Pubitemid 13188658)
49. Miles L, Davis M, Walker D (2011). Phasic and sustained fear are pharmacologically dissociable in rats. Neuropsychopharmacology 36: 1563-1574.
50. Missig G, Ayers LW, Schulkin J, Rosen JB (2010). Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 35: 2607-2616.
51. Morgan CA, Grillon C, Southwick SM, Davis M, Charney DS (1995). Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry 38: 378-385.
52. Neumann ID (2008). Brain oxytocin: A key regulator of emotional and social behaviors in both females and males. J Neuroendocrinol 20: 858-865. (Pubitemid 351858739)
53. Pardridge WM (2005). The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2: 3-14. (Pubitemid 40128022)
54. Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K (1996). Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol Behav 60: 1311-1315. (Pubitemid 26389064)
55. Petersson M, Hulting AL, Uvnas-Moberg K (1999). Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett 264: 41-44. (Pubitemid 29195944)
56. Pole N, Neylan TC, Best SR, Orr SP, Marmar CR (2003). Fearpotentiated startle and posttraumatic stress symptoms in urban police officers. J Traum Stress 16: 471-479. (Pubitemid 37280227)
57. Pole N, Neylan TC, Otte C, Henn-Hasse C, Metzler TJ, Marmar CR (2009). Prospective prediction of posttraumatic stress disorder symptoms using fear potentiated auditory startle responses. Biol Psychiatry 65: 235-240.
58. Reeb-Sutherland BC, Helfinstein SM, Degnan KA, Pérez-Edgar K, Henderson HA, Lissek S et al (2009). Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J Am Acad Child Adolesc Psychiatry 48: 610-617.
59. Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B et al (2006). Anxiolytic-like activity of oxytocin in male mice: Behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) 185: 218-225. (Pubitemid 43363618)
60. Rosen JB, Schulkin J (1998). From normal fear to pathological anxiety. Psychol Rev 105: 325-350. (Pubitemid 128457850)
61. Rotzinger S, Lovejoy DA, Tan LA (2010). Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31: 736-756.
62. Sawchenko P, Swanson L (1985). Relationship of oxytocin pathways to the control of neuroendocrine and autonomic function, In: Amico J, Robinson A (eds). Oxytocin: Clinical and Laboratory Studies. Elsevier: Amsterdam. pp 87-103.
63. Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S et al (2011). Oxytocin administration attenuates stress reactivity in borderline personality disorder: A pilot study. Psychoneuroendocrinology; doi:10.1016/j.psyneuen.2011. 03.013.
64. Simpson JB (1975). Subfornical organ involvement in angiotensininduced drinking, In: Fitzsimons JT, Peters-Haefeli L (eds). Control Mechanisms of Drinking. Springer-Verlag: New York.
65. Slattery DA, Neumann ID (2010). Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 58: 56-61.
66. Sofroniew MV (1983). Morphology of vasopressin and oxytocin neurones and their central and vascular projections. Prog Brain Res 60: 101-114.
67. Stivers JA, Kaltwasser MT, Hill PS, Hruby VJ, Crawley JN (1988). Ventral tegmental oxytocin induces grooming. Peptides 9 (Suppl 1): 223-231.
68. Tribollet E, Dubois-Dauphin M, Dreifuss JJ, Barberis C, Jard S (1992). Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann N Y Acad Sci 652: 29-38.
69. Uvnäs-Moberg K, Ahlenius S, Hillegaart V, Alster P (1994). High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav 49: 101-106.
70. Van Erp AM, Kruk MR, De Kloet ER (1993a). Induction of grooming in resting rats by intracerebroventricular oxytocin but not by adrenocorticotropic hormone-(1-24) and alpha-melanocyte- stimulating hormone. Eur J Pharmacol 232: 217-221. (Pubitemid 23080197)
71. Van Erp AM, Kruk MR, Semple DM, Verbeet DW (1993b). Initiation of self-grooming in resting rats by local PVH infusion of oxytocin but not alpha-MSH. Brain Res 607: 108-112. (Pubitemid 23104953)
72. Veening JG, de Jong T, Barendregt HP (2010). Oxytocin-messages via the cerebrospinal fluid: Behavioral effects; a review. Physiol Behav 101: 193-210.
73. Viviani D, Stoop R (2008). Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog Brain Res 170: 207-218. (Pubitemid 352024377)
74. Walker DL, Davis M (2002a). Quantifying fear potentiated startle using absolute vs proportional increase scoring methods: Implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) 164: 318-328. (Pubitemid 35340999)
75. Walker DL, Davis M (2002b). The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 71: 379-392. (Pubitemid 34117707)
76. Wilbarger JL, McIntosh DN, Winkielman P (2009). Startle modulation in autism: Positive affective stimuli enhance startle response. Neuropsychologia 47: 1323-1331.
77. Windle RJ, Shanks N, Lightman SL, Ingram CD (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138: 2829-2834. (Pubitemid 27258513)